Concepedia

Giovanni Melillo

GM

Statistics

Publications

81

Citations

16.4K

H-Index

45

Active since

1988

Affiliations

National Cancer Institute(Current)

Science Applications International Corporation (United States)

Frederick National Laboratory for Cancer Research

Center for Cancer Research

Istituto Giannina Gaslini

Giovanni Melillo is an author at National Cancer Institute specializing in oncology, medicine, and pharmacology.

Publications per year

1988–2022

81

Publications

81

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text

Medicine, Oncology, Radiation Oncology +15

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Regulation of the Chemokine Receptor CXCR4 by Hypoxia

Tiziana Schioppa, Badarch Uranchimeg, Alessandra Saccani et al. · The Journal of Experimental Medicine · 2003 · 833 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +17

A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.

Giovanni Melillo, Tiziana Musso, Antonio Sica et al. · The Journal of Experimental Medicine · 1995 · 631 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Echinomycin, a Small-Molecule Inhibitor of Hypoxia-Inducible Factor-1 DNA-Binding Activity

Dehe Kong, Eun‐Jung Park, Andrew G. Stephen et al. · Cancer Research · 2005 · 513 citations · Full text

Medicine, Oncology, Pharmacology +10

1–5 of 81